1 min readJan 7, 2019
I actually address this question in part 3 of the series that I just wrote:
I actually address this question in part 3 of the series that I just wrote:
Longevity maximalist currently building rejuvenating gene therapies based on in vivo partial cellular reprogramming with Yamanaka factors.